Forest Laboratories files for FDA approval of new antidepressant drug

Forest Laboratories has filed for marketing approval from the Food and Drug Administration (FDA) for its new antidepressant drug levomilnacipran, which is in the same class of drugs as the antidepressant Effexor. The drugs are classified as serotonin norepinephrine reuptake inhibitors (SNRIs).

Read more about the new SNRI antidepressant drug…

0 Responses to “Forest Laboratories files for FDA approval of new antidepressant drug”



  1. Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s




Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 434 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.


%d bloggers like this: